The Transcriptomics Market was estimated at US$ 5.8 billion in 2021 and is expected to grow at a CAGR of 6.8% during 2022-2028 to reach US$ ~11.40 billion in 2028.
In 2021, North America is projected to be the largest transcriptomics market, driven by new releases, product approvals, partnerships, and acquisitions by leading market players.